[1]
|
Bonfili, L., Cecarini, V., Gogoi, O., et al. (2021) Microbiota Modulation as Preventative and Therapeutic Approach in Alzheimer’s Disease. FEBS Journal, 288, 2836-2855. https://doi.org/10.1111/febs.15571
|
[2]
|
Long, J.M. and Holtzman, D.M. (2019) Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell, 179, 312-339. https://doi.org/10.1016/j.cell.2019.09.001
|
[3]
|
Rusek, M., Pluta, R., Ulamek-Koziol, M., et al. (2019) Ketogenic Diet in Alzheimer’s Disease. International Journal of Molecular Sciences, 20, Article No. 3892. https://doi.org/10.3390/ijms20163892
|
[4]
|
Liu, S., Gao, J., Zhu, M., et al. (2020) Gut Microbiota and Dysbiosis in Alzheimer’s Disease: Implications for Pathogenesis and Treatment. Molecular Neurobiology, 57, 5026-5043. https://doi.org/10.1007/s12035-020-02073-3
|
[5]
|
Gilbert, J.A., Blaser, M.J., Caporaso, J.G., et al. (2018) Current Understanding of the Human Microbiome. Nature Medicine, 24, 392-400. https://doi.org/10.1038/nm.4517
|
[6]
|
Sochocka, M., Donskow-Lysoniewska, K., Diniz, B.S., et al. (2019) The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer’s Disease—A Critical Review. Molecular Neurobiology, 56, 1841-1851.
https://doi.org/10.1007/s12035-018-1188-4
|
[7]
|
Ling, Z., Liu, X., Cheng, Y., et al. (2022) Gut Microbiota and Aging. Critical Reviews in Food Science and Nutrition, 62, 3509-3534. https://doi.org/10.1080/10408398.2020.1867054
|
[8]
|
Askarova, S., Umbayev, B., Masoud, A.R., et al. (2020) The Links between the Gut Microbiome, Aging, Modern Lifestyle and Alzheimer’s Disease. Frontiers in Cellular and Infection Microbiology, 10, Article No. 104.
https://doi.org/10.3389/fcimb.2020.00104
|
[9]
|
Tan, J., McKenzie, C., Potamitis, M., et al. (2014) The Role of Short-Chain Fatty Acids in Health and Disease. Advances in Immunology, 121, 91-119. https://doi.org/10.1016/B978-0-12-800100-4.00003-9
|
[10]
|
Schoeler, M. and Caesar, R. (2019) Dietary Lipids, Gut Microbiota and Lipid Metabolism. Reviews in Endocrine and Metabolic Disorders, 20, 461-472. https://doi.org/10.1007/s11154-019-09512-0
|
[11]
|
Matt, S.M., Allen, J.M., Lawson, M.A., et al. (2018) Butyrate and Dietary Soluble Fiber Improve Neuroinflammation Associated with Aging in Mice. Frontiers in Immunology, 9, Article No. 1832.
https://doi.org/10.3389/fimmu.2018.01832
|
[12]
|
Vanmechelen, E., Vanderstichele, H., Davidsson, P., et al. (2000) Quantification of Tau Phosphorylated at Threonine 181 in Human Cerebrospinal Fluid: A Sandwich ELISA with a Synthetic Phosphopeptide for Standardization. Neuroscience Letters, 285, 49-52. https://doi.org/10.1016/S0304-3940(00)01036-3
|
[13]
|
Rosenberg, R.N., Fu, M. and Lambracht-Washington, D. (2018) Active Full-Length DNA Abeta42 Immunization in 3xTg-AD Mice Reduces Not Only Amyloid Deposition But Also Tau Pathology. Alzheimer’s Research & Therapy, 10, Article No. 115. https://doi.org/10.1186/s13195-018-0441-4
|
[14]
|
Sheng, C., Yang, K., He, B., et al. (2022) Combination of Gut Microbiota and Plasma Amyloid-Beta as a Potential Index for Identifying Preclinical Alzheimer’s Disease: A Cross-Sectional Analysis from the SILCODE Study. Alzheimer’s Research & Therapy, 14, Article No. 35. https://doi.org/10.1186/s13195-022-00977-x
|
[15]
|
Hong, M., Zhukareva, V., Vogelsberg-Ragaglia, V., et al. (1998) Mutation-Specific Functional Impairments in Distinct Tau Isoforms of Hereditary FTDP-17. Science, 282, 1914-1917. https://doi.org/10.1126/science.282.5395.1914
|
[16]
|
Dong, S., Duan, Y., Hu, Y., et al. (2012) Advances in the Pathogenesis of Alzheimer’s Disease: A Re-Evaluation of Amyloid Cascade Hypothesis. Translational Neurodegeneration, 1, Article No. 18.
https://doi.org/10.1186/2047-9158-1-18
|
[17]
|
Halle, A., Hornung, V., Petzold, G.C., et al. (2008) The NALP3 Inflammasome Is Involved in the Innate Immune Response to Amyloid-Beta. Nature Immunology, 9, 857-865. https://doi.org/10.1038/ni.1636
|
[18]
|
Nizami, S., Hall-Roberts, H., Warrier, S., et al. (2019) Microglial Inflammation and Phagocytosis in Alzheimer’s Disease: Potential Therapeutic Targets. British Journal of Pharmacology, 176, 3515-3532.
https://doi.org/10.1111/bph.14618
|
[19]
|
Varnum, M.M. and Ikezu, T. (2012) The Classification of Microglial Activation Phenotypes on Neurodegeneration and Regeneration in Alzheimer’s Disease Brain. Archivum Immunologiae et Therapiae Experimentalis (Warsz), 60, 251-266.
https://doi.org/10.1007/s00005-012-0181-2
|
[20]
|
Parker, A., Fonseca, S. and Carding, S.R. (2020) Gut Microbes and Metabolites as Modulators of Blood-Brain Barrier Integrity and Brain Health. Gut Microbes, 11, 135-157. https://doi.org/10.1080/19490976.2019.1638722
|
[21]
|
Wikoff, W.R., Anfora, A.T., Liu, J., et al. (2009) Metabolomics Analysis Reveals Large Effects of Gut Microflora on Mammalian Blood Metabolites. Proceedings of the National Academy of Sciences of the United States of America, 106, 3698-3703. https://doi.org/10.1073/pnas.0812874106
|
[22]
|
Barrett, E., Ross, R.P., O’Toole, P.W., et al. (2012) Gamma-Aminobutyric Acid Production by Culturable Bacteria from the Human Intestine. Journal of Applied Microbiology, 113, 411-417.
https://doi.org/10.1111/j.1365-2672.2012.05344.x
|
[23]
|
Asti, A. and Gioglio, L. (2014) Can a Bacterial Endotoxin Be a Key Factor in the Kinetics of Amyloid Fibril Formation? Journal of Alzheimer’s Disease, 39, 169-179. https://doi.org/10.3233/JAD-131394
|
[24]
|
Kahn, M.S., Kranjac, D., Alonzo, C.A., et al. (2012) Prolonged Elevation in Hippocampal Abeta and Cognitive Deficits Following Repeated Endotoxin Exposure in the Mouse. Behavioural Brain Research, 229, 176-184.
https://doi.org/10.1016/j.bbr.2012.01.010
|
[25]
|
Cerovic, M., Forloni, G. and Balducci, C. (2019) Neuroinflammation and the Gut Microbiota: Possible Alternative Therapeutic Targets to Counteract Alzheimer’s Disease? Frontiers in Aging Neuroscience, 11, Article No. 284.
https://doi.org/10.3389/fnagi.2019.00284
|
[26]
|
Zhao, Y. and Lukiw, W.J. (2018) Bacteroidetes Neurotoxins and Inflammatory Neurodegeneration. Molecular Neurobiology, 55, 9100-9107. https://doi.org/10.1007/s12035-018-1015-y
|
[27]
|
Maguire, M. and Maguire, G. (2019) Gut Dysbiosis, Leaky Gut, and Intestinal Epithelial Proliferation in Neurological Disorders: Towards the Development of a New Therapeutic Using Amino Acids, Prebiotics, Probiotics, and Postbiotics. Reviews in the Neurosciences, 30, 179-201. https://doi.org/10.1515/revneuro-2018-0024
|
[28]
|
Wang, X., Sun, G., Feng, T., et al. (2019) Sodium Oligomannate Therapeutically Remodels Gut Microbiota and Suppresses Gut Bacterial Amino Acids-Shaped Neuroinflammation to Inhibit Alzheimer’s Disease Progression. Cell Research, 29, 787-803. https://doi.org/10.1038/s41422-019-0216-x
|
[29]
|
Li, F., Wang, Y., Song, X., et al. (2022) The Intestinal Microbial Metabolite Nicotinamide n-Oxide Prevents Herpes Simplex Encephalitis via Activating Mitophagy in Microglia. Gut Microbes, 14, Article ID: 2096989.
https://doi.org/10.1080/19490976.2022.2096989
|
[30]
|
Lasry, A., Zinger, A. and Ben-Neriah, Y. (2016) Inflammatory Networks Underlying Colorectal Cancer. Nature Immunology, 17, 230-240. https://doi.org/10.1038/ni.3384
|
[31]
|
Muller, P.A., Matheis, F., Schneeberger, M., et al. (2020) Microbiota-Modulated CART(+) Enteric Neurons Autonomously Regulate Blood Glucose. Science, 370, 314-321. https://doi.org/10.1126/science.abd6176
|
[32]
|
De Giorgio, R., Guerrini, S., Barbara, G., et al. (2004) Inflammatory Neuropathies of the Enteric Nervous System. Gastroenterology, 126, 1872-1883. https://doi.org/10.1053/j.gastro.2004.02.024
|
[33]
|
Chalazonitis, A. and Rao, M. (2018) Enteric Nervous System Manifestations of Neurodegenerative Disease. Brain Research, 1693, 207-213. https://doi.org/10.1016/j.brainres.2018.01.011
|
[34]
|
Bonaz, B., Bazin, T. and Pellissier, S. (2018) The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis. Frontiers in Neuroscience, 12, Article No. 49. https://doi.org/10.3389/fnins.2018.00049
|
[35]
|
Lin, L., Zheng, L.J. and Zhang, L.J. (2018) Neuroinflammation, Gut Microbiome, and Alzheimer’s Disease. Molecular Neurobiology, 55, 8243-8250. https://doi.org/10.1007/s12035-018-0983-2
|
[36]
|
Valles-Colomer, M., Falony, G., Darzi, Y., et al. (2019) The Neuroactive Potential of the Human Gut Microbiota in Quality of Life and Depression. Nature Microbiology, 4, 623-632. https://doi.org/10.1038/s41564-018-0337-x
|
[37]
|
Fung, T.C., Olson, C.A. and Hsiao, E.Y. (2017) Interactions between the Microbiota, Immune and Nervous Systems in Health and Disease. Nature Neuroscience, 20, 145-155. https://doi.org/10.1038/nn.4476
|
[38]
|
Spielman, L.J., Gibson, D.L. and Klegeris, A. (2018) Unhealthy Gut, Unhealthy Brain: The Role of the Intestinal Microbiota in Neurodegenerative Diseases. Neurochemistry International, 120, 149-163.
https://doi.org/10.1016/j.neuint.2018.08.005
|
[39]
|
Sochocka, M., Zwolinska, K. and Leszek, J. (2017) The Infectious Etiology of Alzheimer’s Disease. Current Neuropharmacology, 15, 996-1009. https://doi.org/10.2174/1570159X15666170313122937
|
[40]
|
Pisa, D., Alonso, R., Fernandez-Fernandez, A.M., et al. (2017) Polymicrobial Infections in Brain Tissue from Alzheimer’s Disease Patients. Scientific Reports, 7, Article No. 5559. https://doi.org/10.1038/s41598-017-05903-y
|
[41]
|
Salas, I.H., Burgado, J. and Allen, N.J. (2020) Glia: Victims or Villains of the Aging Brain? Neurobiology of Disease, 143, Article ID: 105008. https://doi.org/10.1016/j.nbd.2020.105008
|
[42]
|
Sun, Y.X., Jiang, X.J., Lu, B., et al. (2020) Roles of Gut Microbiota in Pathogenesis of Alzheimer’s Disease and Therapeutic Effects of Chinese Medicine. Chinese Journal of Integrative Medicine, 28, 1048-1056.
https://doi.org/10.1007/s11655-020-3274-5
|
[43]
|
Fakhoury, M. (2018) Microglia and Astrocytes in Alzheimer’s Disease: Implications for Therapy. Current Neuropharmacology, 16, 508-518. https://doi.org/10.2174/1570159X15666170720095240
|
[44]
|
Liu, P., Wu, L., Peng, G., et al. (2019) Altered Microbiomes Distinguish Alzheimer’s Disease from Amnestic Mild Cognitive Impairment and Health in a Chinese Cohort. Brain, Behavior, and Immunity, 80, 633-643.
https://doi.org/10.1016/j.bbi.2019.05.008
|
[45]
|
Zhuang, Z.Q., Shen, L.L., Li, W.W., et al. (2018) Gut Microbiota Is Altered in Patients with Alzheimer’s Disease. Journal of Alzheimer’s Disease, 63, 1337-1346. https://doi.org/10.3233/JAD-180176
|
[46]
|
Haran, J.P., Bhattarai, S.K., Foley, S.E., et al. (2019) Alzheimer’s Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway. mBio, 10, e00632-19. https://doi.org/10.1128/mBio.00632-19
|
[47]
|
Giau, V.V., Wu, S.Y., Jamerlan, A., et al. (2018) Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer’s Disease. Nutrients, 10, Article No. 1765. https://doi.org/10.3390/nu10111765
|
[48]
|
Borsom, E.M., Lee, K. and Cope, E.K. (2020) Do the Bugs in Your Gut Eat Your Memories? Relationship between Gut Microbiota and Alzheimer’s Disease. Brain Sciences, 10, Article No. 814.
https://doi.org/10.3390/brainsci10110814
|
[49]
|
Sherwin, E., Sandhu, K.V., Dinan, T.G., et al. (2016) May the Force Be With You: The Light and Dark Sides of the Microbiota-Gut-Brain Axis in Neuropsychiatry. CNS Drugs, 30, 1019-1041.
https://doi.org/10.1007/s40263-016-0370-3
|
[50]
|
Jiang, C., Li, G., Huang, P., et al. (2017) The Gut Microbiota and Alzheimer’s Disease. Journal of Alzheimer’s Disease, 58, 1-15. https://doi.org/10.3233/JAD-161141
|
[51]
|
Hu, X., Wang, T. and Jin, F. (2016) Alzheimer’s Disease and Gut Microbiota. Science China Life Sciences, 59, 1006-1023.
https://doi.org/10.1007/s11427-016-5083-9
|
[52]
|
Harach, T., Marungruang, N., Duthilleul, N., et al. (2017) Reduction of Abeta Amyloid Pathology in APPPS1 Transgenic Mice in the Absence of Gut Microbiota. Scientific Reports, 7, Article No. 41802.
https://doi.org/10.1038/srep46856
|
[53]
|
Abraham, D., Feher, J., Scuderi, G.L., et al. (2019) Exercise and Probiotics Attenuate the Development of Alzheimer’s Disease in Transgenic Mice: Role of Microbiome. Experimental Gerontology, 115, 122-131.
https://doi.org/10.1016/j.exger.2018.12.005
|
[54]
|
Chen, D., Yang, X., Yang, J., et al. (2017) Prebiotic Effect of Fructooligosaccharides from Morinda officinalis on Alzheimer’s Disease in Rodent Models by Targeting the Microbiota-Gut-Brain Axis. Frontiers in Aging Neuroscience, 9, Article No. 403. https://doi.org/10.3389/fnagi.2017.00403
|
[55]
|
Angelucci, F., Cechova, K., Amlerova, J., et al. (2019) Antibiotics, Gut Microbiota, and Alzheimer’s Disease. Journal of Neuroinflammation, 16, Article No. 108. https://doi.org/10.1186/s12974-019-1494-4
|
[56]
|
Vogt, N.M., Kerby, R.L., Dill-McFarland, K.A., et al. (2017) Gut Microbiome Alterations in Alzheimer’s Disease. Scientific Reports, 7, Article No. 13537. https://doi.org/10.1038/s41598-017-13601-y
|
[57]
|
Saji, N., Niida, S., Murotani, K., et al. (2019) Analysis of the Relationship between the Gut Microbiome and Dementia: A Cross-Sectional Study Conducted in Japan. Scientific Reports, 9, Article No. 1008.
https://doi.org/10.1038/s41598-018-38218-7
|
[58]
|
Nguyen, T., Fujimura, Y., Mimura, I., et al. (2018) Cultivable Butyrate-Producing Bacteria of Elderly Japanese Diagnosed with Alzheimer’s Disease. Journal of Microbiology, 56, 760-771. https://doi.org/10.1007/s12275-018-8297-7
|
[59]
|
Pluta, R., Ulamek-Koziol, M., Januszewski, S., et al. (2020) Gut Microbiota and Pro/Prebiotics in Alzheimer’s Disease. Aging (Albany NY), 12, 5539-5550. https://doi.org/10.18632/aging.102930
|
[60]
|
Mukherjee, S., Joardar, N., Sengupta, S., et al. (2018) Gut Microbes as Future Therapeutics in Treating Inflammatory and Infectious Diseases: Lessons from Recent Findings. The Journal of Nutritional Biochemistry, 61, 111-128.
https://doi.org/10.1016/j.jnutbio.2018.07.010
|
[61]
|
Ding, L., et al. (2019) Efficacy of Different Probiotic Protocols in Irritable Bowel Syndrome: A Network Meta-Analysis. Medicine (Baltimore), 98, e16068. https://doi.org/10.1097/MD.0000000000016068
|
[62]
|
Ho, L., Ono, K., Tsuji, M., et al. (2018) Protective Roles of Intestinal Microbiota Derived Short Chain Fatty Acids in Alzheimer’s Disease-Type Beta-Amyloid Neuropathological Mechanisms. Expert Review of Neurotherapeutics, 18, 83-90. https://doi.org/10.1080/14737175.2018.1400909
|
[63]
|
Kobayashi, Y., Sugahara, H., Shimada, K., et al. (2017) Therapeutic Potential of Bifidobacterium breve Strain A1 for Preventing Cognitive Impairment in Alzheimer’s Disease. Scientific Reports, 7, Article No. 13510.
https://doi.org/10.1038/s41598-017-13368-2
|
[64]
|
Kobayashi, Y., Kuhara, T., Oki, M., et al. (2019) Effects of Bifidobacterium breve A1 on the Cognitive Function of Older Adults with Memory Complaints: A Randomised, Double-Blind, Placebo-Controlled Trial. Beneficial Microbes, 10, 511-520. https://doi.org/10.3920/BM2018.0170
|
[65]
|
Pistollato, F., Iglesias, R.C., Ruiz, R., et al. (2018) Nutritional Patterns Associated with the Maintenance of Neurocognitive Functions and the Risk of Dementia and Alzheimer’s Disease: A Focus on Human Studies. Pharmacological Research, 131, 32-43. https://doi.org/10.1016/j.phrs.2018.03.012
|
[66]
|
Akbari, E., Asemi, Z., Daneshvar, K.R., et al. (2016) Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer’s Disease: A Randomized, Double-Blind and Controlled Trial. Frontiers in Aging Neuroscience, 8, Article No. 256. https://doi.org/10.3389/fnagi.2016.00256
|